Curie Capital (investor - Venture Capital)

curiecapital.nl

See something wrong or missing? Let us know

Offices:Amsterdam

Curie Capital is a life science focused venture capital firm from the Netherlands

Average round investment:31M USD

Average number per year:1.6

Distribution: 2025 (3)2024 (2)2023 (1)2022 (1)2020 (1)

Portfolio companies: Netherlands

Laigo Bio

Avidicure

Sirius Medical See the entire list

Mostly invests in:

Netherlands (8) Health services (8)

See the entire list

Showing 3 of 8 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Curie Capital mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Curie Capital

Name		Criteria
	Evonik Venture Capital GmbH 91%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 1.7 Active last 12 months: Yes
	Clay Capital 91%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 1.8 Active last 12 months: Yes
	Morningside Ventures 90%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 3.4 Active last 12 months: Yes
	LIOF 90%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 1.5 Active last 12 months: Yes
	Gimv 90%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 2.3 Active last 12 months: Yes
	Seroba Life Sciences 90%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 2.5 Active last 12 months: Yes
	Hadean Ventures 90%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 2.6 Active last 12 months: Yes
	BioGeneration Ventures 89%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 3.3 Active last 12 months: Yes
	F-Prime Capital 89%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 3.9 Active last 12 months: Yes
	Pureos Bioventures 89%	Range for average deal size: 20M - 50M USD Similar verticals: Health services, Biotech, Pharma Similar business models: B2B, SAAS Common investees countries: Netherlands Average number of deals per year: 4.2 Active last 12 months: Yes